These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6778761)

  • 1. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat.
    Whittle BJ
    Gastroenterology; 1981 Jan; 80(1):94-8. PubMed ID: 6778761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effect of PGI2, 7-oxo-PGI2 and 17-aza-PGF2 alpha derivate on the development of indomethacin-induced intestinal mucosal damage in rats.
    Garamszegi M; Beró T; Jávor T; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):349-53. PubMed ID: 6397968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostacyclin (PGI2) formation in the rat small-intestine and gastric mucosa by the ulcerogen, indomethacin [proceedings].
    Whittle BJ
    Br J Pharmacol; 1978 Nov; 64(3):438P. PubMed ID: 363210
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of (S)-4-(1-(5-chloro-2-(4-fluorophenyoxy)benzamido)ethyl) benzoic acid (CJ-42794), a selective antagonist of prostaglandin E receptor subtype 4, on ulcerogenic and healing responses in rat gastrointestinal mucosa.
    Takeuchi K; Tanaka A; Kato S; Aihara E; Amagase K
    J Pharmacol Exp Ther; 2007 Sep; 322(3):903-12. PubMed ID: 17578900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of indomethacin-induced gastric ulcer in rats.
    Kapui Z; Boér K; Rózsa I; Blaskó G; Hermecz I
    Arzneimittelforschung; 1993 Jul; 43(7):767-71. PubMed ID: 8369011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin produces gastric antral ulcers in the refed rat.
    Satoh H; Inada I; Hirata T; Maki Y
    Gastroenterology; 1981 Oct; 81(4):719-25. PubMed ID: 7262516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-salicylate in contrast with acetylsalicylic acid prevents gastric antral and intestinal ulcers produced by indomethacin in the refed rat.
    Ezer E
    Acta Physiol Hung; 1985; 65(3):263-6. PubMed ID: 4013765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
    Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
    Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric effects of the selective cyclooxygenase-2 inhibitor, celecoxib, in the rat.
    Coppelli G; Guaita E; Spaggiari S; Coruzzi G
    Dig Liver Dis; 2004 Apr; 36(4):265-70. PubMed ID: 15115339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat.
    Ligumsky M; Golanska EM; Hansen DG; Kauffman GL
    Gastroenterology; 1983 Apr; 84(4):756-61. PubMed ID: 6402412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.